Dr. Tam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1441 Eastlake Ave
Los Angeles, CA 90089Phone+1 323-865-3105
Summary
- I am a Hematologist Oncologist specializing in blood and marrow transplantation and cancer cellular therapy at USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC. He is triple board certified in medical oncology, hematology and internal medicine. My clinical and research interest is in stem cell transplantation and chimeric antigen receptor (CAR) T-cell therapy, with a particular focus on leukemia, lymphoma, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms.
Education & Training
University of Southern CaliforniaMBA, Executive MBA, 2023
Stanford Health CareFellowship, Blood & Bone Marrow Transplant, 2019 - 2020
SUNY Downstate Health Sciences UniversityFellowship, Hematology and Medical Oncology, 2016 - 2019- Woodhull Medical and Mental Health CenterResidency, Internal Medicine, 2013 - 2016
St. George's University School of MedicineClass of 2013
University of PennsylvaniaPost Baccalaureate, Special Science Program, 2008 - 2009- University of California, Los AngelesBS, Chemical Engineering, 2001 - 2007
Certifications & Licensure
CA State Medical License 2015 - 2025
NV State Medical License 2024 - 2025
NY State Medical License 2016 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- National Board of Physicians and Surgeons Hematology
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Awards, Honors, & Recognition
- Outstanding Faculty Award Keck Medicine of USC, Division of Hematology, 2023
- Southern California Rising Stars Award Super Doctors, 2022-2023
Clinical Trials
- A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS Start of enrollment: 2020 Oct 06
- A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD) Start of enrollment: 2021 Mar 04
- Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML) Start of enrollment: 2021 Feb 09
- Join now to see all
Publications & Presentations
PubMed
- 24 citationsCheckpoint inhibitors in head and neck cancer: current knowledge and perspectives.Bachar Samra, Eric Tam, Babak Baseri, Iuliana Shapira
Journal of Investigative Medicine. 2018-10-01 - 7 citationsComplete resolution of bone metastases with pembrolizumab.Gurinder Sidhu, Eric Tam
Japanese Journal of Clinical Oncology. 2019-07-01 - 67 citationsEffects of an LL-37-derived antimicrobial peptide in an animal model of biofilm Pseudomonas sinusitisSri Kiran Chennupati, Alexander G. Chiu, Edwin Tamashiro, Caroline A. Banks, Michael Cohen
American Journal of Rhinology & Allergy. 2009-01-01
Press Mentions
Preventing and Treating COVID-19 in Cancer Patients: Challenges in the Omicron EraMarch 10th, 2023
Medicare Reconsiders Paying for Seniors’ Spine Operations at Surgery CentersJuly 30th, 2018- As Surgery Centers Boom, Patients Are Paying with Their LivesMarch 2nd, 2018
- Join now to see all
Professional Memberships
- Phi Delta Epsilon - CA GammaAlumni
- Member
- Member
- Member
- American Society of Transplantation and Cellular TherapyMember
- Member
Other Languages
- Chinese (Cantonese)
External Links
- Keck Medicine of USChttps://providers.keckmedicine.org/provider/Eric+Leon+Tam/207-3316483
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
